Dr Tan Yew Oo
MBBS(Singapore), FRCP (Canada), FACP (USA), FRACP (Aus), FRCP(Edinburgh), DRCP(Glasgow), FAMS(Medical Oncology), Diplomate of American Board of Internal Medicine, Haematology and Medical Oncology.
Dr Tan Yew Oo is currently the specialist in medical oncology with Icon SOC Farrer Park, Gleneagles and Mt Alvernia.
He was formerly the Professor of Medicine at the Faculty of Medicine, National University of Singapore (NUS), and Chief of Medicine, along with Head of the Division of Haematology-Oncology, at National University Hospital (NUH). Dr Tan was a tenured faculty staff of NUS from 1978 to 1993, during which he set up the specialty of Medical Oncology at National University Hospital. He has been the mentor and teacher to medical oncologists across Singapore.
After he went into private practice, he remained active in medical education and postgraduate training. Dr Tan served in the Specialist Training Committee of Medical Oncology, Academy of Medicine-MOH, Singapore, and was Chairman of the National Committee on Cancer Care, Medical Research Council and consultant to the Health Science Authority.
He was a Member of the Board of Directors of SingHealth between 2000 and 2006 and served as Member of Board of Directors of Eastern Health Alliance between 2014 to 2017 and now Member of Board of Directors of SingHealth since 2018 till present. Dr Tan was a member of Singapore Medical Council (SMC) Review Committee from 2013 to 2014 and currently serves as member of Complaints Committee of SMC. He has been a member of Medishield Life Council since June 2015. He has been appointed as member of Agency for Care Effectiveness (ACE) since 2016 and recently appointed as member of National Advisory Committee on Cancer (NACC).
He was the examiner in Master of Medicine (M. Med) and taught the Family Medicine physicians in Oncology. He remains active in clinical cancer research and continues to participate in Phase III clinical trials on novel anti-cancer agents.
Dr Tan has published in several medical and peer reviewed journals and has been invited to speak at regional and international medical meetings. He served on many Drug Advisory Boards of many pharmaceutical companies.
Dr Tan’s special interests include lung, breast and gastrointestinal cancers, lymphomas and liver cancer. He has cared for a wide-range of cancers, both haematologic malignancies and solid tumours, and conducts second opinion consultations.